Navigation Links
Greenphire's ClinCard Technology Platform selected by top 5 pharmaceutical company for long-term global clinical trial
Date:11/6/2012

KING OF PRUSSIA, Pa., Nov. 6, 2012 /PRNewswire-iReach/ -- Greenphire, the leading provider of payment technologies for the clinical trials industry, today announced that a top 5 pharmaceutical company will use its ClinCard Technology Platform in a large, phase III clinical trial.  The trial will include over 1,000 patients across 6 countries and is expected to last over five years. 

The ClinCard system will allow the sponsor to execute quick and accurate payments to patients globally in 4 different currencies and will reduce the administrative burden on sites by replacing traditional manual processes with automated electronic payments. In previous studies, ClinCard has decreased time spent on administrative tasks related to patient payments by up to 90% and has reduced associated costs by up to 60%. In addition to reducing time and costs for clinical research sites, the ClinCard was selected for its proven ability to increase patient retention.

"By combining real-time patient payments in local currencies with automated patient messaging systems, the ClinCard system has been shown to increase patient retention by up to 11.7%, a particularly important consideration in a long-term study such as this," said Sam Whitaker, Greenphire's CEO and co-founder.  "I am pleased that the ClinCard solution can help to ensure the success of this study and that Greenphire's vision for automated payment processes is increasingly accepted within the industry as a way to reduce administration, costs, and risk in complex clinical trials."

About Greenphire

Greenphire is the industry's leading provider of clinical payment technology, designed to change the way research professionals work. We leverage our proprietary workflow automation and advanced web‐based payment technologies to help our clients improve operational efficiency, reduce costs, mitigate regulatory risks, increase subject retention and compliance, and produce quantifiable results that improve clinical operations and strategic planning. Learn more at www.greenphire.com.

Media Contact: Shana Jalbert Greenphire, (215) 948-9260, shana.jalbert@greenphire.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Greenphire
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Fuse Science Set to Redefine OTC and Pharmaceutical Delivery with Roll-On Application Technology
2. Micell Technologies Announces Issuance of Core Technology Patent
3. Cytos Biotechnology Ltd Reports Third Quarter 2012 Financial Results, Recent Development and Outlook
4. Study Published in Otology & Neurotology Shows Benefits of Cochlear Implant Sound Processor with Dual-Microphone Technology
5. LABSCO Implements Leading-Edge Technology to Support Growth and Seize Opportunities in the Clinical Laboratory Market
6. ECRI Institute Releases Top 10 Health Technology Hazards Report for 2013
7. Parios Regenerative Sciences, Inc. Licenses Exclusive Rights to Organic Nanotechnology for Skin Repair
8. Missouris PSE Blocking Technology Leading To Progress In Battle Against Meth
9. Kentuckys PSE Blocking Technology Leading To Progress In Battle Against Meth
10. Parker Signs Licensing Agreement with Vanderbilt for Exoskeleton Technology and Targets Commercial Launch in 2014
11. West Health Institute licenses Kinect-based physical therapy technology to Reflexion Health; West Health Investment Fund makes $4.25 million investment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/13/2017)... 2017 On Thursday, January 12, ... and the S&P 500 edged lower at the closing ... session in bearish territories. Taking into consideration yesterday,s market ... morning: Myriad Genetics Inc. (NASDAQ: MYGN ), ... Holdings Inc. (NASDAQ: INCR ), and La ...
(Date:1/13/2017)...  Secretary of Health Karen Murphy today ... at Misericordia University and discussed the Wolf Administration,s efforts ... . "The opioid epidemic is the ... my professional career," Secretary Murphy said. "This area of ... by heroin and prescription opioid overdoses. Across the commonwealth ...
(Date:1/13/2017)... , Jan. 13, 2017 Concord Medical Services ... CCM ), a leading specialty hospital management solution ... and diagnostic imaging centers in China ... fund with Zhongrong International Trust Co., Ltd. ("ZRT"). ... to set up Zhongrong Taihe Healthcare Fund in October ...
Breaking Medicine Technology:
(Date:1/16/2017)... ... January 16, 2017 , ... Board-certified oculoplastic surgeon Dr. ... the official journal of The American Society for Aesthetic Plastic Surgery, in which ... is designed to correct drooping, retracted lower eyelids, which usually result from genetics, ...
(Date:1/16/2017)... ... ... NexTec Group has been selected as a member of the Bob Scott’s VAR ... field of midmarket financial software. , Members of the VAR Stars were selected based ... on revenue and those firms chosen represent a wide range of size and many ...
(Date:1/15/2017)... California (PRWEB) , ... January 15, 2017 , ... "On ... stylistic slideshow with complete customization and ease," said Christina Austin - CEO of Pixel ... controls so that users can edit the style and animation of their slideshows. Place ...
(Date:1/14/2017)... (PRWEB) , ... January 14, 2017 , ... ... the distinctions among their expanding line of activated charcoal products. With more and ... importance of categorizing their products according to how they cater to specific needs. ...
(Date:1/13/2017)... ... 13, 2017 , ... The 18th European Congress: Perspectives in Lung Cancer will ... This Congress is expertly designed to meet the educational needs of European oncology ... , Chaired by Dr. Giorgio V. Scagliotti, Professor of Oncology at the University of ...
Breaking Medicine News(10 mins):